The Global Fund Call for Proposals: Invitation to Manufacturers
The Global Fund to Fight AIDS, Tuberculosis and Malaria (Global Fund) provides grants to support national and global efforts to increase access, care and treatment in approximately 140 countries like the following one Manufacturers of Antiretroviral (HIV/AIDS), Antihepatitis B and C, Antituberculosis and Antimalarial medicines Are Invited to Submit An Expression of Interest For Product Evaluation by the Global Fund Expert Review Panel.
The purpose of this expression of interest is to invite submissions of product dossiers for review by the Expert Review Panel for which there could be supply bottlenecks, including the cases where there are two or less products of the same formulation available in the global market that are already WHO prequalified or approved by a stringent regulatory authority. This expression of interest may include, as well, some formulations even when there are more than two eligible products in the market, in cases where it has been determined that such products are eligible for distribution to a restricted number of countries only, or when it has been identified that the available production capacity of the qualified products cannot cover the demand.
Eligibility:
- Completeness of the documents submitted to Global Fund Secretariat for External Review Panel review is determined by the Global Fund quality assurance specialist. All the documents listed in the instructions for submission (in annex) must be included by the applicant. Incomplete submissions will not be forwarded to the External Review Panel.
- The eligibility of the submissions for External Review Panel review will not be considered by the Global Fund Secretariat. It is the External Review Panel’s responsibility to review and to judge the eligibility and whether or not to perform the risk-benefit assessment of the products submitted.
- For any product found not to comply with the required standards during previous External Review Panel review, all documentation requested should be re-submitted in full.
Read more here.
Proposals deadline January 8, 2021.
